Heat Biologics

Heat Biologics' core team has experienced the devastating effects of cancer or its current treatment methods firsthand or through the pain of loved ones. We are dedicated to helping to rid mankind of this deadly disorder by developing safe and effective treatments for a wide variety of different cancers.

Heat Biologics’ ImPACT Therapy (Immune Pan-Antigen Cytotoxic Therapy) is a first-in-class fully-human adjuvant technology that specifically stimulates the tumor cell-killing arm of the immune system toward the specific ‘fingerprint’ of a particular cancer. We are entering Phase II Clinical Trials for patients with non-small cell lung cancer and will be initiating clinical trials in bladder cancer in early-2013.